138 related articles for article (PubMed ID: 24446157)
1. Estrogen withdrawal from osteoblasts and osteocytes causes increased mineralization and apoptosis.
Brennan MÁ; Haugh MG; O'Brien FJ; McNamara LM
Horm Metab Res; 2014 Jul; 46(8):537-45. PubMed ID: 24446157
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4.
Ahuja SS; Zhao S; Bellido T; Plotkin LI; Jimenez F; Bonewald LF
Endocrinology; 2003 May; 144(5):1761-9. PubMed ID: 12697681
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
Wiren KM; Toombs AR; Semirale AA; Zhang X
Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
[TBL] [Abstract][Full Text] [Related]
4. Estrogen plus estrogen receptor antagonists alter mineral production by osteoblasts in vitro.
Brennan O; O'Brien FJ; McNamara LM
Horm Metab Res; 2012 Jan; 44(1):47-53. PubMed ID: 22124881
[TBL] [Abstract][Full Text] [Related]
5. Establishment of an osteoid preosteocyte-like cell MLO-A5 that spontaneously mineralizes in culture.
Kato Y; Boskey A; Spevak L; Dallas M; Hori M; Bonewald LF
J Bone Miner Res; 2001 Sep; 16(9):1622-33. PubMed ID: 11547831
[TBL] [Abstract][Full Text] [Related]
6. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
[TBL] [Abstract][Full Text] [Related]
7. IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts.
Bakker AD; Kulkarni RN; Klein-Nulend J; Lems WF
J Dent Res; 2014 Apr; 93(4):394-9. PubMed ID: 24492932
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an osteocyte-like cell line, MLO-Y4.
Kato Y; Windle JJ; Koop BA; Mundy GR; Bonewald LF
J Bone Miner Res; 1997 Dec; 12(12):2014-23. PubMed ID: 9421234
[TBL] [Abstract][Full Text] [Related]
9. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
Heino TJ; Hentunen TA; Väänänen HK
Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
[TBL] [Abstract][Full Text] [Related]
10. Effects of ageing, prolonged estrogen deficiency and zoledronate on bone tissue mineral distribution.
Brennan MA; Gleeson JP; O'Brien FJ; McNamara LM
J Mech Behav Biomed Mater; 2014 Jan; 29():161-70. PubMed ID: 24090875
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate affects signaling from mechanically-stimulated osteocytes towards osteoclasts and osteoblasts.
Bakker AD; Zandieh-Doulabi B; Klein-Nulend J
Bone; 2013 Mar; 53(1):112-9. PubMed ID: 23234812
[TBL] [Abstract][Full Text] [Related]
13. Osteocyte biology: its implications for osteoporosis.
Bonewald LF
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):101-4. PubMed ID: 15615083
[TBL] [Abstract][Full Text] [Related]
14. Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2012 Feb; 676(1-3):26-33. PubMed ID: 22192930
[TBL] [Abstract][Full Text] [Related]
15. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
Wang W; Olson D; Cheng B; Guo X; Wang K
J Ethnopharmacol; 2012 Jun; 142(1):168-74. PubMed ID: 22543168
[TBL] [Abstract][Full Text] [Related]
16. The role of estrogen in the control of rat osteocyte apoptosis.
Tomkinson A; Gevers EF; Wit JM; Reeve J; Noble BS
J Bone Miner Res; 1998 Aug; 13(8):1243-50. PubMed ID: 9718192
[TBL] [Abstract][Full Text] [Related]
17. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures.
Nakano Y; Addison WN; Kaartinen MT
Bone; 2007 Oct; 41(4):549-61. PubMed ID: 17669706
[TBL] [Abstract][Full Text] [Related]
18. The effects of fulvestrant, an estrogen receptor antagonist, on the proliferation, differentiation and mineralization of osteoprecursor cells.
Park JB
Mol Med Rep; 2013 Feb; 7(2):555-8. PubMed ID: 23179494
[TBL] [Abstract][Full Text] [Related]
19. Estrogen deficiency attenuates fluid flow-induced [Ca
Deepak V; Kayastha P; McNamara LM
FASEB J; 2017 Jul; 31(7):3027-3039. PubMed ID: 28363954
[TBL] [Abstract][Full Text] [Related]
20. Studying osteocyte function using the cell lines MLO-Y4 and MLO-A5.
Rosser J; Bonewald LF
Methods Mol Biol; 2012; 816():67-81. PubMed ID: 22130923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]